Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab + RT in Locally Advanced SCCHN
NCT03349710Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2017
- Primary completion
- Oct 2019
- Modality
- Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 3 trial of nivolumab in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Bristol Myers Squibb. Started Dec 2017; status: completed.
02
Drugs
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT03349710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03349710.